Pinsent Masons appoints third life sciences partner in Amsterdam

Joining the firm’s European life sciences team, and further strengthening its Netherlands-based technology, science and industry capabilities, Judith is both Dutch and US qualified and has vast experience acting on multijurisdictional matters – particularly for pharma and biological companies.

Recognised by Managing Intellectual Property as being in the Top 250 Women in IP globally, Judith is also the co-founder and board member of the Female Intellectual Property Experts – a women’s network for intellectual property professionals.

Commenting on Judith’s appointment, global head of IP & life sciences, Clare Tunstall said:

“Judith is a fantastic addition to our European life sciences team. Being a forum of choice in European patent actions, The Netherlands is a key jurisdiction for our clients. As an international market leader, Judith’s cross-border patent litigation and medicines regulatory expertise enables us to fully support clients in this important market.”

With a degree in chemistry and law, Judith joins a full-service team where many hold relevant scientific qualifications and degrees, including in genetics, medicinal chemistry, human biology, and biochemistry – testament to the in-depth sector focus of the firm.

Commenting on her appointment, Judith Krens added:

"Pinsent Masons shows a real passion for the life sciences sector and I am impressed by their approach of being a strategic partner for their life sciences clients by offering a fully integrated practice across multiple jurisdictions. In addition, I am delighted to see the firm’s commitment to having women in leadership positions. I am convinced that diverse and inclusive teams not only make people happier but can really bring the services offered to the highest level. I am tremendously proud to join the firm and I hope to be able to bring on board both my experience as a life sciences specialist and a female leader and contribute to further growth."

Judith will work closely with recently appointed partners András Kupecz and Machteld Hiemstra.